Evidence map›Paper›PMID 40871138›Full record

ArticlePolymers2025

A Study on Phosphorous-Based Flame Retardants for Transparent PET Composites: Fire, Mechanical, and Optical Performance.

Sara Villanueva-Díez, Alberto Sánchez-de-Andrés

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sara Villanueva-DíezTECNALIA, Basque Research and Technology Alliance (BRTA), Parque Científico y Tecnológico de Gipuzkoa Mikeletegi Pasealekua, 2, E-20009 Donostia-San Sebastián, Gipuzkoa, Spain.ORCID 0000-0002-6152-7610
Alberto Sánchez-de-AndrésTECNALIA, Basque Research and Technology Alliance (BRTA), Parque Científico y Tecnológico de Gipuzkoa Mikeletegi Pasealekua, 2, E-20009 Donostia-San Sebastián, Gipuzkoa, Spain.ORCID 0000-0002-2169-6217

Funding

Basque Government EXP KK-2023/00056
6 · The paper itself

Abstract

Flame-retardant poly (ethylene terephthalate) composites (FR PET) have been developed with the potential to be used as substrates in applications where flexibility and transparency are required. Several phosphorous-based flame retardants of a different nature were selected here for compounding by melt blending with a low-molecular-weight PET polymer. The fire reaction, transparency, and mechanical properties were analyzed. TGA and cone calorimetry were used to elucidate the gas-phase and condensed-phase actions of flame retardants and their effectivity. Cone calorimeters showed an improved performance with the addition of flame retardants, particularly a reduction in generated heat, improving the FGI (fire growth index) value. However, a V0 classification (following the UL94 standard) was achieved only with the addition of an organic phosphonate, Aflammit PCO900, to the PET matrix. This behavior was linked to the early reaction of this flame retardant in the gas phase, in addition to a plastification effect that causes the removal of the polymer from the incident flame. The presence of flame retardants reduced the transparency of composites over the neat PET, but, nevertheless, a good optical performance remained. No special effect was observed on the crystallization parameters. Therefore, the increase in opacity can be attributed to the poor miscibility of flame retardants and/or differences in the diffraction index of the polymer and FR additives.

Indexed as

arylphosphatescyclotriphosphazeneDOPOflame-retardant transparent PETphosphonated organic flame retardantphosphorous-based flame retardantprinted electronics

Identifiers

PMID40871138
PMCPMC12389156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.